| # | Drug | Count |
|---|---|---|
| 0 | GEMCITABINE HYDROCHLORIDE | 19 |
| 1 | LIDOCAINE HYDROCHLORIDE | 17 |
| 2 | HYALURONIDASE | 16 |
| 3 | GEMCITABINE | 15 |
| 4 | TACROLIMUS | 15 |
| 5 | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | 14 |
| 6 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 14 |
| 7 | TACROLIMUS OINTMENT 0.1% | 14 |
| 8 | BUPIVACAINE | 13 |
| 9 | BUPIVACAINE HYDROCHLORIDE IN DEXTROSE | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INOTUZUMAB OZOGAMICIN | 7 | 0.0023 |
| 1 | BUPIVACAINE HYDROCHLORIDE WITH DEXTROSE | 1 | 0.0022 |
| 2 | BUPIVACAINE HYDROCHLORIDE IN DEXTROSE | 13 | 0.0017 |
| 3 | BUPIVACAINE | 13 | 0.0014 |
| 4 | IDARUBICIN HYDROCHLORIDE | 1 | 0.0009 |
| 5 | CLADRIBINE | 7 | 0.0007 |
| 6 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 5 | 0.0006 |
| 7 | GEMCITABINE HYDROCHLORIDE | 19 | 0.0004 |
| 8 | PEGASPARGASE | 4 | 0.0003 |
| 9 | LIDOCAINE HYDROCHLORIDE | 17 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Amide Local Anesthetic [EPC] | 17 |
| 1 | Antiarrhythmic [EPC] | 17 |
| 2 | Corticosteroid [EPC] | 16 |
| 3 | Endoglycosidase [EPC] | 16 |
| 4 | Ester Local Anesthetic [EPC] | 13 |
| 5 | Non-Standardized Chemical Allergen [EPC] | 13 |
| 6 | Microtubule Inhibitor [EPC] | 12 |
| 7 | Alkylating Drug [EPC] | 9 |
| 8 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 9 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 8 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Endoglycosidase [EPC] | 16 | 0.0086 |
| 1 | CD22-directed Immunoconjugate [EPC] | 7 | 0.0023 |
| 2 | Asparagine-specific Enzyme [EPC] | 4 | 0.0003 |
| 3 | Ester Local Anesthetic [EPC] | 13 | 0.0003 |
| 4 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 7 | 0.0002 |
| 5 | Amide Local Anesthetic [EPC] | 17 | 0.0002 |
| 6 | Antiarrhythmic [EPC] | 17 | 0.0002 |
| 7 | Non-Standardized Chemical Allergen [EPC] | 13 | 0.0002 |
| 8 | Topoisomerase Inhibitor [EPC] | 8 | 0.0001 |
| 9 | CD30-directed Immunoconjugate [EPC] | 1 | 0.0001 |